brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - Æxlishemjandi lyf - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
fluconazol krka hart hylki 150 mg
krka sverige ab - fluconazolum inn - hart hylki - 150 mg
prasugrel krka filmuhúðuð tafla 10 mg
krka, d.d., novo mesto - prasugrelum inn - filmuhúðuð tafla - 10 mg
sandimmun innrennslisþykkni, lausn 50 mg/ml
novartis healthcare a/s - ciclosporinum inn - innrennslisþykkni, lausn - 50 mg/ml
citalopram stada (citalopram pcd) filmuhúðuð tafla 20 mg
stada arzneimittel ag - citalopram hydrobromide - filmuhúðuð tafla - 20 mg
diflucan mixtúruduft, lausn 10 mg/ml
pfizer aps - fluconazolum inn - mixtúruduft, lausn - 10 mg/ml
eliquis (lyfjaver) filmuhúðuð tafla 5 mg
lyfjaver ehf. - apixabanum inn - filmuhúðuð tafla - 5 mg
kairasec tafla 8 mg
medical valley invest ab - candesartanum cílexetíl - tafla - 8 mg
methotrexate pfizer (methotrexate wyeth) tafla 2,5 mg
pfizer aps - methotrexatum inn - tafla - 2,5 mg
rivaroxaban wh (rivaroxavan pharos) filmuhúðuð tafla 20 mg
williams & halls ehf.* - rivaroxabanum inn - filmuhúðuð tafla - 20 mg